Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-02-24 @ 5:07 AM
Study NCT ID:
NCT05060003
Status:
TERMINATED
Last Update Posted:
2024-02-20
First Post:
2021-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Sponsor:
Washington University School of Medicine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stage II Melanoma | View |
Keywords: